- Home
- BACC vs MREO Comparison
BACC vs MREO Comparison
Compare BACC & MREO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BACC
- MREO
- Stock Information
- Founded
- BACC 2025
- MREO 2015
- Country
- BACC United States
- MREO United Kingdom
- Employees
- BACC N/A
- MREO N/A
- Industry
- BACC
- MREO Biotechnology: Pharmaceutical Preparations
- Sector
- BACC
- MREO Health Care
- Exchange
- BACC Nasdaq
- MREO Nasdaq
- Market Cap
- BACC 279.6M
- MREO 311.8M
- IPO Year
- BACC 2025
- MREO N/A
- Fundamental
- Price
- BACC $10.01
- MREO $2.01
- Analyst Decision
- BACC
- MREO Strong Buy
- Analyst Count
- BACC 0
- MREO 5
- Target Price
- BACC N/A
- MREO $7.40
- AVG Volume (30 Days)
- BACC 26.6K
- MREO 1.6M
- Earning Date
- BACC 01-01-0001
- MREO 11-11-2025
- Dividend Yield
- BACC N/A
- MREO N/A
- EPS Growth
- BACC N/A
- MREO N/A
- EPS
- BACC N/A
- MREO N/A
- Revenue
- BACC N/A
- MREO $500,000.00
- Revenue This Year
- BACC N/A
- MREO N/A
- Revenue Next Year
- BACC N/A
- MREO $72.16
- P/E Ratio
- BACC N/A
- MREO N/A
- Revenue Growth
- BACC N/A
- MREO N/A
- 52 Week Low
- BACC $9.95
- MREO $1.47
- 52 Week High
- BACC $10.06
- MREO $4.40
- Technical
- Relative Strength Index (RSI)
- BACC N/A
- MREO 51.00
- Support Level
- BACC N/A
- MREO $1.98
- Resistance Level
- BACC N/A
- MREO $2.08
- Average True Range (ATR)
- BACC 0.00
- MREO 0.11
- MACD
- BACC 0.00
- MREO -0.01
- Stochastic Oscillator
- BACC 0.00
- MREO 17.72
About BACC Blue Acquisition Corp. Class A Ordinary Shares
Blue Acquisition Corp is a blank check company.
About MREO Mereo BioPharma Group plc
Mereo BioPharma Group PLC is a United Kingdom (U.K.) based biopharmaceutical company focused on the development of therapeutics for rare diseases. The company has developed a portfolio of late-stage clinical product candidates, and its two rare disease product candidates are setrusumab for the treatment of osteogenesis imperfecta (OI) and alvelestat primarily for the treatment of severe alpha-1 antitrypsin deficiency-associated lung disease (AATD-LD).